Hacker News Reader

While I'm sure there's real value in the drug, articles like this one in Reuters [0], noting how much Novo Nordisk is spending on promotion, makes me suspicious that it's being overprescribed.

[0] https://www.reuters.com/investigates/special-report/health-o...

View on HN

it turns out you don't actually have to spend a lot on marketing a miracle weight loss drug, word spreads pretty well on its own. lots of companies spend lots of money on promoting drugs and basically none every go viral like this. you don't hear phrases like "ozempic face" because of novo's marketing budget. you can even see this in how people still talk about ozempic despite the actual weight loss labelled name being wegovy, and despite zepbound (tirzepatide) arguably offering a better option with lower side-effect burden through dual agonism of GIP.

Reply on news.ycombinator.com